Scholarly Index
John S. Lazo
University of Virginia; 16,412 total citations; 419 total publications; best world rank #34
University of Virginia
16,412Total citations
419Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bioactive Compounds and Antitumor Agents | Lifetime | 53 | US 31 | 98.98 |
| Protein Tyrosine Phosphatases | Lifetime | 34 | US 21 | 98.22 |
| Cancer therapeutics and mechanisms | Lifetime | 369 | US 207 | 98.01 |
| Peptidase Inhibition and Analysis | Lifetime | 768 | US 343 | 97.54 |
| Trace Elements in Health | Lifetime | 418 | US 177 | 97.50 |
| Ubiquitin and proteasome pathways | Lifetime | 592 | US 298 | 97.49 |
| Synthesis and Biological Evaluation | Lifetime | 652 | US 182 | 96.85 |
| Galectins and Cancer Biology | Lifetime | 336 | US 124 | 96.57 |
| Heterocyclic Compound Synthesis and Bioactivity | Lifetime | 885 | US 69 | 96.38 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 647 | US 276 | 96.94 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 703 | US 360 | 95.68 |
| 14-3-3 protein interactions | Lifetime | 658 | US 255 | 81.38 |
| Protein Tyrosine Phosphatases | 2021-2025 | 74 | US 25 | 85.18 |
| Inflammation biomarkers and pathways | 2021-2025 | 731 | US 183 | 11.73 |